AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16144950 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 13
Study 16144950 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 13
Study 12110062 — intervention group
Group type: EXPERIMENTAL
Intervention: Study of Osteoporotic Fractures guidelines
Number of subjects: 428
Study 12110062 — intervention group
Group type: EXPERIMENTAL
Intervention: World Health Organization (WHO) recommendations
Number of subjects: 428
Study 12110062 — intervention group
Group type: EXPERIMENTAL
Intervention: National Osteoporosis Foundation guidelines
Number of subjects: 428
Study 12110062 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO guidelines based on low BMD alone
Number of subjects: 428
Study 9890620 — intervention group
Group type: EXPERIMENTAL
Intervention: Malignant group (treated with antineoplastic agents)
Number of subjects: 162
Study 9890620 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmalignant group (received transfusions for nonmalignant diseases)
Number of subjects: 162
Study 9890620 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV group
Number of subjects: 162
Study 9890620 — intervention group
Group type: COMPARATOR
Intervention: HBV and non-A-C hepatitis groups
Number of subjects: 162
Study 7745044 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination (IUI)
Number of subjects: 46
Study 7745044 — intervention group
Group type: COMPARATOR
Intervention: Timed intercourse with cyclic, low-dose prednisolone (20 mg)
Number of subjects: 46
Study 2405533 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron therapy
Number of subjects: 0
Study 2405533 — intervention group
Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 0
Study 2405533 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed schedule (neutrons + photons)
Number of subjects: 0
Study 6775301 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release nitroglycerin capsules
Number of subjects: 25
Study 30039991 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Volume, High-Intensity Training (HIT)
Number of subjects: 16
Study 30039991 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity, High-Volume Training (HVT)
Number of subjects: 16
Study 30115425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (<120 mm Hg)
Number of subjects: 6875
Study 30115425 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure control (130-139 mm Hg)
Number of subjects: 6875
Study 27329373 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational-interviewing intervention
Number of subjects: 52
Study 27329373 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling sessions
Number of subjects: 52
Study 24263324 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI + B
Number of subjects: 596
Study 24263324 — intervention group
Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 596
Study 24263324 — intervention group
Group type: COMPARATOR
Intervention: Brief motivational intervention (BMI)
Number of subjects: 596
Study 22873530 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tofacitinib twice daily
Number of subjects: 611
Study 22873530 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg tofacitinib twice daily
Number of subjects: 611
Study 22873530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 611
Study 19287182 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile cardiopulmonary bypass (CPB)
Number of subjects: 50
Study 19287182 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile cardiopulmonary bypass (CPB)
Number of subjects: 50
Study 17786056 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II Receptor Blockers (ARBs)
Number of subjects: 301
Study 17786056 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-Converting Enzyme (ACE) inhibitors
Number of subjects: 301
Study 17786056 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 301
Study 17786056 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 301
Study 17786056 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Channel Blockers (CCBs)
Number of subjects: 301
Study 17786056 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers
Number of subjects: 301
Study 17786056 — intervention group
Group type: EXPERIMENTAL
Intervention: ARBs
Number of subjects: 301
Study 15027165 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition
Number of subjects: 0
Study 15027165 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition
Number of subjects: 0
Study 15027165 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition
Number of subjects: 0
Study 12109357 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium treatment
Number of subjects: 0
Study 10077049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pedicular clamping (IPC)
Number of subjects: 86
Study 10077049 — intervention group
Group type: COMPARATOR
Intervention: Continuous pedicular clamping (CPC)
Number of subjects: 86
Study 7586390 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 558
Study 7586390 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 558
Study 2322085 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning light exposure
Number of subjects: 13
Study 2322085 — intervention group
Group type: COMPARATOR
Intervention: Evening light exposure
Number of subjects: 13
Study 85177 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-recorded peak expiratory-flow rate (P.E.F.R.)
Number of subjects: 50
Study 30578164 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes education plus diabetes health coaching
Number of subjects: 365
Study 30578164 — intervention group
Group type: COMPARATOR
Intervention: Usual diabetes education
Number of subjects: 365
Study 28894283 — intervention group
Group type: EXPERIMENTAL
Intervention: JinqiJiangtang tablets (JQJT tablets)
Number of subjects: 400
Study 28894283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 25643028 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (target BrAC = .08 g%) in lab context
Number of subjects: 157
Study 25643028 — intervention group
Group type: COMPARATOR
Intervention: Placebo in lab context
Number of subjects: 157
Study 25643028 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (target BrAC = .08 g%) in simulated bar context
Number of subjects: 157
Study 25643028 — intervention group
Group type: COMPARATOR
Intervention: Placebo in simulated bar context
Number of subjects: 157
Study 23499270 — intervention group
Group type: EXPERIMENTAL
Intervention: XIENCE V
Number of subjects: 3687
Study 23499270 — intervention group
Group type: COMPARATOR
Intervention: Taxus Express(2)
Number of subjects: 3687
Study 21115863 — intervention group
Group type: COMPARATOR
Intervention: IV amifostine (200 mg/m(2) daily for 3 minutes, 15 to 30 minutes before irradiation)
Number of subjects: 291
Study 21115863 — intervention group
Group type: EXPERIMENTAL
Intervention: SC amifostine (500 mg; two sites; 20 to 60 minutes before irradiation)
Number of subjects: 291
Study 19263186 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of oral L‐amphetamine sulfate for 29 days
Number of subjects: 151
Study 19263186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 16765378 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training regimen
Number of subjects: 26
Study 16765378 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 26
Study 10937952 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg
Number of subjects: 18
Study 10937952 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 12.5 mg
Number of subjects: 18
Study 10937952 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 18
Study 10937952 — intervention group
Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 18
Study 8904626 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg tablet
Number of subjects: 24
Study 8904626 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 mg tablet
Number of subjects: 24
Study 8904626 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 mg solution
Number of subjects: 24
Study 8904626 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 mg tablet with food
Number of subjects: 24
Study 8904626 — intervention group
Group type: COMPARATOR
Intervention: 850 mg tablet fasting
Number of subjects: 24
Study 1365471 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% percutaneous niflumic acid gel applied three times daily for 7 days
Number of subjects: 59
Study 1365471 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel applied three times daily for 7 days
Number of subjects: 59
Study 1365471 — intervention group
Group type: EXPERIMENTAL
Intervention: Niflumic acid gel
Number of subjects: 59
Study 6346781 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine treatment
Number of subjects: 147
Study 31797232 — intervention group
Group type: EXPERIMENTAL
Intervention: Online sampling and anonymous interviewing
Number of subjects: 15000
Study 31797232 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized experiment
Number of subjects: 15000
Study 29979327 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified minimally invasive single‐incision technique (MSIT)
Number of subjects: 40
Study 29979327 — intervention group
Group type: COMPARATOR
Intervention: Traditional trap‐door incision technique (TDIT)
Number of subjects: 40
Study 27628506 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate tones training
Number of subjects: 50
Study 27628506 — intervention group
Group type: COMPARATOR
Intervention: Delayed tones training
Number of subjects: 50
Study 25306742 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride (Ganaton) oral tablets 50 mg, 3 times daily for 8 weeks
Number of subjects: 96
Study 23200288 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Training (ERT) + Treatment as Usual (TAU)
Number of subjects: 109
Study 23200288 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 109
Study 20718542 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimuli experienced by more similar others (Study 1, 2, and 3)
Number of subjects: 3
Study 20718542 — intervention group
Group type: COMPARATOR
Intervention: Stimuli experienced by less similar others (Study 1, 2, and 3)
Number of subjects: 3
Study 18252070 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio yogurt (150 ml of live strawberry-flavoured yogurt for 12 days)
Number of subjects: 369
Study 18252070 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial yogurt
Number of subjects: 369
Study 18252070 — intervention group
Group type: COMPARATOR
Intervention: No yogurt
Number of subjects: 369
Study 16295218 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help treatment
Number of subjects: 192
Study 16295218 — intervention group
Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 192
Study 12450697 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 30
Study 12450697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10803488 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 44
Study 10803488 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 44
Study 10803488 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 44
Study 10803488 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 44
Study 10803488 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 44
Study 8564429 — intervention group
Group type: EXPERIMENTAL
Intervention: NaCl adaptation
Number of subjects: 0
Study 8564429 — intervention group
Group type: COMPARATOR
Intervention: KCl
Number of subjects: 0
Study 31709879 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise challenge in non-EIB asthmatics (n = 31)
Number of subjects: 91
Study 31709879 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise challenge in EIB asthmatics (n = 25)
Number of subjects: 91
Study 31709879 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable asthmatic children
Number of subjects: 91
Study 31709879 — intervention group
Group type: COMPARATOR
Intervention: Children with asthma exacerbation
Number of subjects: 91
Study 31709879 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with ACT score
Number of subjects: 91
Study 31709879 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with baseline FEV1 level
Number of subjects: 91
Study 27918682 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrepetition rest configuration (32 maximum intended velocity repetitions, 10RM load, 17.4 s of rest between each repetition)
Number of subjects: 13
Study 27918682 — intervention group
Group type: COMPARATOR
Intervention: Traditional configuration (4 sets of 8 repetitions at maximum intended velocity, 10RM load, 3‐min pause between sets)
Number of subjects: 13
Study 27918682 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training protocols
Number of subjects: 13
Study 25995055 — intervention group
Group type: EXPERIMENTAL
Intervention: NEI-VFQ-25 composite score
Number of subjects: 165
Study 25995055 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression model
Number of subjects: 165
Study 25995055 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall health-related quality of life (QOL)
Number of subjects: 165
Study 25995055 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision-specific QOL
Number of subjects: 165
Study 25995055 — intervention group
Group type: EXPERIMENTAL
Intervention: IIH treatment
Number of subjects: 165
Study 25995055 — intervention group
Group type: EXPERIMENTAL
Intervention: QOL assessment
Number of subjects: 165
Study 23416014 — intervention group
Group type: EXPERIMENTAL
Intervention: Meteorological events (temperature drops, wind speed increases, relative humidity increases)
Number of subjects: 9406
Study 23416014 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 9406
Study 21707766 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin (8 mg/daily for a maximum of 8 weeks)
Number of subjects: 187
Study 21707766 — intervention group
Group type: COMPARATOR
Intervention: Control group (drinking 2 L of water daily)
Number of subjects: 187
Study 19772449 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR inhaled insulin
Number of subjects: 385
Study 19772449 — intervention group
Group type: COMPARATOR
Intervention: SC insulin (regular human insulin or insulin lispro)
Number of subjects: 385
Study 17326352 — intervention group
Group type: EXPERIMENTAL
Intervention: epi-LASIK
Number of subjects: 57
Study 17326352 — intervention group
Group type: COMPARATOR
Intervention: LASEK
Number of subjects: 57
Study 17326352 — intervention group
Group type: COMPARATOR
Intervention: PRK
Number of subjects: 57
Study 15161789 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg/day
Number of subjects: 93
Study 11139307 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine 740 mg/m² immediately prior to chemotherapy
Number of subjects: 84
Study 11139307 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 84
Study 11139307 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostine with chemotherapy
Number of subjects: 84
Study 9722203 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced regimen (6 MU daily for 12 days, 6 MU thrice a week for 22 weeks, 3 MU thrice a week for 24 weeks)
Number of subjects: 244
Study 9722203 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (3 MU thrice a week for 24 weeks)
Number of subjects: 244
Study 9722203 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced regimen
Number of subjects: 244
Study 7989961 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival applications of HPMC membranes containing 20% chlorhexidine and 40% doxycycline, applied twice a week for 6 weeks.
Number of subjects: 11
Study 7989961 — intervention group
Group type: COMPARATOR
Intervention: Subgingival scaling and root planing (control group), performed at 0, 1, 3, and 6 weeks.
Number of subjects: 11
Study 2498550 — intervention group
Group type: EXPERIMENTAL
Intervention: Short term perioperative antibiotic (Group III)
Number of subjects: 404
Study 2498550 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative antibiotic regimens (Group I and II)
Number of subjects: 404
Study 2498550 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of penicillin and streptomycin (Group II)
Number of subjects: 404
Study 2498550 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephamendole used perioperatively (Group III)
Number of subjects: 404
Study 982011 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve prolapse patients
Number of subjects: 17
Study 982011 — intervention group
Group type: COMPARATOR
Intervention: Control group (17 patients without MVP)
Number of subjects: 17
Study 30660196 — intervention group
Group type: EXPERIMENTAL
Intervention: Yerba mate (YM) 1000 mL/day
Number of subjects: 142
Study 30660196 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (GT) 1000 mL/day
Number of subjects: 142
Study 30660196 — intervention group
Group type: COMPARATOR
Intervention: Apple tea (AT, control group) 1000 mL/day
Number of subjects: 142
Study 28318997 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) plus medical therapy
Number of subjects: 3120
Study 28318997 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 3120
Study 28318997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure at randomisation
Number of subjects: 3120
Study 28318997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic hypertension (> 90 mmHg)
Number of subjects: 3120
Study 25393036 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification (Phaco)
Number of subjects: 82
Study 25393036 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification and viscogonioplasty (Phaco‐VGP)
Number of subjects: 82
Study 25393036 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification (Phaco) and Combined phacoemulsification and viscogonioplasty (Phaco‐VGP)
Number of subjects: 82
Study 23397315 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.2 mg)
Number of subjects: 57
Study 23397315 — intervention group
Group type: COMPARATOR
Intervention: Periarticular multimodal drug injection
Number of subjects: 57
Study 23397315 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 57
Study 21999886 — intervention group
Group type: EXPERIMENTAL
Intervention: Orodispersible escitalopram (2 × 10 mg and 1 × 20 mg)
Number of subjects: 29
Study 21999886 — intervention group
Group type: COMPARATOR
Intervention: Conventional escitalopram (2 × 10 mg)
Number of subjects: 29
Study 18269385 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee arthroscopy
Number of subjects: 100
Study 17176206 — intervention group
Group type: EXPERIMENTAL
Intervention: Family treatments combined with pharmacotherapy
Number of subjects: 62
Study 14531590 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (FujI II LC)
Number of subjects: 37
Study 14531590 — intervention group
Group type: COMPARATOR
Intervention: Resin composite (Z 250/Single Bond)
Number of subjects: 37
Study 10744204 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorometholone 0.1% acetate
Number of subjects: 60
Study 10744204 — intervention group
Group type: COMPARATOR
Intervention: Fluorometholone 0.2%
Number of subjects: 60
Study 8617070 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-intensity treatment (early mobilization and sustained maximal inflations)
Number of subjects: 78
Study 8617070 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity treatment (early mobilization, sustained maximal inflations, and single-handed percussions)
Number of subjects: 78
Study 1399734 — intervention group
Group type: EXPERIMENTAL
Intervention: Conformal techniques (CG)
Number of subjects: 46
Study 1399734 — intervention group
Group type: COMPARATOR
Intervention: Non-conformal techniques (NCG)
Number of subjects: 46
Study 4078729 — intervention group
Group type: EXPERIMENTAL
Intervention: 96 mg of cocaine (intranasal pretreatment)
Number of subjects: 8
Study 4078729 — intervention group
Group type: COMPARATOR
Intervention: 4 mg of cocaine (intranasal pretreatment)
Number of subjects: 8
Study 4078729 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (i.v. injection after intranasal pretreatment)
Number of subjects: 8
Study 4078729 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated administration of cocaine
Number of subjects: 8
Study 31050950 — intervention group
Group type: EXPERIMENTAL
Intervention: Home PBM treatments (n=4), administered three times per week for 12 weeks using the Vielight Neuro Gamma device.
Number of subjects: 8
Study 31050950 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC, n=4) for 12 weeks.
Number of subjects: 8
Study 30587368 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-MAdCAM antibody (PF-00547659)
Number of subjects: 0
Study 30587368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27543885 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-kindness training
Number of subjects: 122
Study 27543885 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness training
Number of subjects: 122
Study 24103740 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological factors (Perceived Stress Scale, Profile of Mood State)
Number of subjects: 99
Study 24103740 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological factors (depression, anger, fatigue)
Number of subjects: 99
Study 24103740 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated current health and HIV status
Number of subjects: 99
Study 22913890 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam 3.75 g/day
Number of subjects: 153
Study 22913890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 20160213 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 65
Study 20160213 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 65
Study 17654442 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0